- Report
- January 2026
- 361 Pages
Global
From €5108EUR$5,850USD£4,422GBP
- Report
- January 2026
- 387 Pages
Global
From €5108EUR$5,850USD£4,422GBP
- Report
- January 2026
- 473 Pages
Global
From €5108EUR$5,850USD£4,422GBP
- Report
- January 2026
- 467 Pages
Global
From €5108EUR$5,850USD£4,422GBP
- Report
- January 2026
- 282 Pages
Global
From €5108EUR$5,850USD£4,422GBP
- Report
- January 2026
- 108 Pages
Global
From €5108EUR$5,850USD£4,422GBP
- Report
- January 2026
- 225 Pages
Global
From €5108EUR$5,850USD£4,422GBP
- Report
- January 2026
- 273 Pages
Global
From €5108EUR$5,850USD£4,422GBP
- Report
- January 2026
- 172 Pages
Global
From €5108EUR$5,850USD£4,422GBP
- Report
- January 2026
- 370 Pages
Global
From €5108EUR$5,850USD£4,422GBP
- Report
- January 2026
- 466 Pages
Global
From €5108EUR$5,850USD£4,422GBP
- Report
- January 2026
- 494 Pages
Global
From €5108EUR$5,850USD£4,422GBP
- Report
- January 2026
- 389 Pages
Global
From €5108EUR$5,850USD£4,422GBP
- Report
- January 2026
- 586 Pages
Global
From €5108EUR$5,850USD£4,422GBP
- Report
- January 2026
- 276 Pages
Global
From €5108EUR$5,850USD£4,422GBP
- Report
- January 2026
- 184 Pages
Global
From €5108EUR$5,850USD£4,422GBP
- Report
- January 2026
- 162 Pages
Global
From €5108EUR$5,850USD£4,422GBP
- Report
- January 2026
- 383 Pages
Global
From €5108EUR$5,850USD£4,422GBP
- Report
- January 2026
- 378 Pages
Global
From €5108EUR$5,850USD£4,422GBP
- Report
- January 2026
- 168 Pages
Global
From €5108EUR$5,850USD£4,422GBP

The Contract Development and Manufacturing Organization (CDMO) market is a subset of the pharmaceutical manufacturing industry. It is composed of companies that provide services to pharmaceutical and biotechnology companies, such as drug development, clinical trial materials, and commercial manufacturing. CDMOs are typically engaged by pharmaceutical companies to outsource the development and manufacturing of their products. This allows the pharmaceutical companies to focus on their core competencies, such as drug discovery and marketing.
CDMOs provide a range of services, including process development, analytical services, formulation development, clinical trial materials, and commercial manufacturing. They also provide regulatory support, such as filing of Investigational New Drug (IND) applications and New Drug Applications (NDAs).
Some of the major players in the CDMO market include Lonza, Patheon, Boehringer Ingelheim, Catalent, and Ajinomoto. Other companies in the market include Recipharm, Jubilant, Vetter, and Fareva. Show Less Read more